Candida albicans is an opportunistic pathogen accounting for the majority of cases of Candida infections. Currently, C. albicans are developing resistance towards different classes of antifungal drugs and this has become a global health burden that does not spare Lebanon. This study aims at determining point mutations in genes known to be involved in resistance acquisition and correlating resistance to virulence and ergosterol content in the azole resistant C. albicans isolate CA77 from Lebanon. This pilot study is the first of its kind to be implemented in Lebanon. We carried out whole genome sequencing of the azole resistant C. albicans isolate CA77 and examined 18 genes involved in antifungal resistance. To correlate genotype to phenotype, we evaluated the virulence potential of this isolate by injecting it into BALB/c mice and we quantified membrane ergosterol. Whole genome sequencing revealed that eight out of 18 genes involved in antifungal resistance were mutated in previously reported and novel residues. These genotypic changes were associated with an increase in ergosterol content but no discrepancy in virulence potential was observed between our isolate and the susceptible C. albicans control strain SC5314. This suggests that antifungal resistance and virulence potential in this antifungal resistant isolate are not correlated and that resistance is a result of an increase in membrane ergosterol content and the occurrence of point mutations in genes involved in the ergosterol biosynthesis pathway.

Biomedical Center Faculty of Medicine in Pilsen Charles University 32300 Pilsen Czech Republic

Department of Microbiology Faculty of Medicine University Hospital in Pilsen Charles University 32300 Pilsen Czech Republic

Department of Natural Sciences Lebanese American University PO Box 36 Byblos Lebanon

Institute of Biodiversity Animal Health and Comparative Medicine University of Glasgow Glasgow UK

Zobrazit více v PubMed

Vazquez JA, Sobel JD. Candidiasis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of Clinical Mycology. 2nd ed. New York: Springer; 2011. pp. 167–206.

Méan M, Marchetti O, Calandra T. Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care. 2008;12:204. doi: 10.1186/cc6212. PubMed DOI PMC

Mayer FL, Wilson D, Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013;4:119–128. doi: 10.4161/viru.22913. PubMed DOI PMC

Campoy S, Adrio JL. Antifungals. Biochem Pharmacol. 2017;133:86–96. doi: 10.1016/j.bcp.2016.11.019. PubMed DOI

Onyewu C, Blankenship JR, Del Poeta M, Heitman J. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei . Antimicrob Agents Chemother. 2003;47:956–964. doi: 10.1128/AAC.47.3.956-964.2003. PubMed DOI PMC

Henry KW, Nickels JT, Edlind TD. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2000;44:2693–2700. doi: 10.1128/AAC.44.10.2693-2700.2000. PubMed DOI PMC

Perlin DS. Mechanisms of echinocandin antifungal drug resistance. Ann N Y Acad Sci. 2015;1354:1–11. doi: 10.1111/nyas.12831. PubMed DOI PMC

Cowen LE, Sanglard D, Howard SJ, Rogers PD, Perlin DS. Mechanisms of antifungal drug resistance. Cold Spring Harb Perspect Med. 2015;5:a019752. doi: 10.1101/cshperspect.a019752. PubMed DOI PMC

Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harb Perspect Med. 2014;4:a019703. doi: 10.1101/cshperspect.a019703. PubMed DOI PMC

Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis. 2017;17:e383–e392. doi: 10.1016/S1473-3099(17)30316-X. PubMed DOI

Barada G, Basma R, Khalaf RA. Microsatellite DNA identification and genotyping of Candida albicans from Lebanese clinical isolates. Mycopathologia. 2008;165:115–125. doi: 10.1007/s11046-008-9089-0. PubMed DOI

Basma R, Barada G, Ojaimi N, Khalaf RA. Susceptibility of Candida albicans to common and novel antifungal drugs, and relationship between the mating type locus and resistance, in Lebanese hospital isolates. Mycoses. 2009;52:141–148. doi: 10.1111/j.1439-0507.2008.01559.x. PubMed DOI

Bitar I, Khalaf RA, Harastani H, Tokajian S. Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients. Biomed Res Int. 2014;2014:1–10. doi: 10.1155/2014/931372. PubMed DOI PMC

Araj GF, Asmar RG, Avedissian AZ. Candida profiles and antifungal resistance evolution over a decade in Lebanon. J Infect Dev Ctries. 2015;9:997–1003. doi: 10.3855/jidc.6550. PubMed DOI

Toutounji M, Tokajian S, Khalaf RA. Genotypic and phenotypic characterization of Candida albicans Lebanese hospital isolates resistant and sensitive to caspofungin. Fungal Genetics and Biology. 2019;127:12–22. doi: 10.1016/j.fgb.2019.02.008. PubMed DOI

Ghaddar N, Anastasiadis E, Halimeh R, Ghaddar A, Dhar R, et al. Prevalence and antifungal susceptibility of Candida albicans causing vaginal discharge among pregnant women in Lebanon. BMC Infect Dis. 2020;20:1–9. doi: 10.1186/s12879-019-4736-2. PubMed DOI PMC

Yazbek S, Barada G, Basma R, Mahfouz J, Khalaf RA. Significant discrepancy between real-time PCR identification and hospital identification of C. albicans from Lebanese patients. Med Sci Monit. 2007;13:MT7–12. PubMed

Liu TT, Lee REB, Barker KS, Lee RE, Wei L, REB L, Rogers PD, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans . Antimicrob Agents Chemother. 2005;49:2226–2236. doi: 10.1128/AAC.49.6.2226-2236.2005. PubMed DOI PMC

Whaley SG, Berkow EL, Rybak JM, Nishimoto AT, Barker KS, et al. Azole antifungal resistance in Candida albicans and emerging non-albicans Candida species. Front Microbiol. 2017;7:2173. doi: 10.3389/fmicb.2016.02173. PubMed DOI PMC

Ruiz-Herrera J, Elorza MV, Valentín E, Sentandreu R. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res. 2006;6:14–29. doi: 10.1111/j.1567-1364.2005.00017.x. PubMed DOI

Awad A, El Khoury P, Wex B, Khalaf RA. Proteomic analysis of a Candida albicans PGA1 null strain. EuPA Open Proteom. 2018;18:1–6. doi: 10.1016/j.euprot.2018.02.001. PubMed DOI PMC

CLSI Performance standard for antifungal susceptibility testing of filamentous fungi. Available from. https://clsi.org/media/3682/m61ed2_sample.pdf

Daher JY, Koussa J, Younes S, Khalaf RA. The Candida albicans Dse1 protein is essential and plays a role in cell wall rigidity, biofilm formation, and virulence. Interdiscip Perspect Infect Dis. 2011;2011:1–9. doi: 10.1155/2011/504280. PubMed DOI PMC

Hashash R, Younes S, Bahnan W, El Koussa J, Maalouf K, et al. Characterisation of PGA1, a putative Candida albicans cell wall protein necessary for proper adhesion and biofilm formation. Mycoses. 2011;54:491–500. doi: 10.1111/j.1439-0507.2010.01883.x. PubMed DOI

Bahnan W, Koussa J, Younes S, Rizk MA, Khalil B, et al. Deletion of the Candida albicans PIR32 results in increased virulence, stress response, and upregulation of cell wall chitin deposition. Mycopathologia. 2012;174:107–119. doi: 10.1007/s11046-012-9533-z. PubMed DOI

Arthington-Skaggs BA, Jradi H, Desai T, Morrison CJ. Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicans . J Clin Microbiol. 1999;37:3332–3337. doi: 10.1128/JCM.37.10.3332-3337.1999. PubMed DOI PMC

Chin C-S, Alexander DH, Marks P, Klammer AA, Drake J, et al. Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data. Nat Methods. 2013;10:563–569. doi: 10.1038/nmeth.2474. PubMed DOI

Chin C-S, Peluso P, Sedlazeck FJ, Nattestad M, Concepcion GT, et al. Phased diploid genome assembly with single-molecule real-time sequencing. Nat Methods. 2016;13:1050–1054. doi: 10.1038/nmeth.4035. PubMed DOI PMC

Bitar I, Medvecky M, Amlerova J, Papagiannitsis CC, Hrabak J. Frequency of mutations associated with resistance to first- and second-line drugs in multidrug-resistant Mycobacterium tuberculosis isolates. J Glob Antimicrob Resist. 2020;22:275–282. doi: 10.1016/j.jgar.2020.03.013. PubMed DOI

Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357–359. doi: 10.1038/nmeth.1923. PubMed DOI PMC

Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004;14:1394–1403. doi: 10.1101/gr.2289704. PubMed DOI PMC

Wang JM, Bennett RJ, Anderson MZ. The genome of the human pathogen Candida albicans is shaped by mutation and cryptic sexual recombination. mBio. 2018;9:e01205–01218. doi: 10.1128/mBio.01205-18. PubMed DOI PMC

Hrabak J, Bitar I, Papagiannitsis CC. Combination of mass spectrometry and DNA sequencing for detection of antibiotic resistance in diagnostic laboratories. Folia Microbiol. 2020;65:233–243. doi: 10.1007/s12223-019-00757-5. PubMed DOI

Löffler J, Einsele H, Hebart H, Schumacher U, Hrastnik C. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains. FEMS Microbiol Lett. 2000;185:59–63. doi: 10.1016/S0378-1097(00)00071-9. PubMed DOI

Rocha MFG, Bandeira SP, de Alencar LP, Melo LM, Sales JA, et al. Azole resistance in Candida albicans from animals: highlights on efflux pump activity and gene overexpression. Mycoses. 2017;60:462–468. doi: 10.1111/myc.12611. PubMed DOI

Sitterlé E, Coste AT, Obadia T, Maufrais C, Chauvel M, et al. Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins. J Antimicrob Chemother. 2020;75:835–848. doi: 10.1093/jac/dkz537. PubMed DOI

Haque A, Rai V, Bahal BS, Shukla S, Lattif AA, et al. Allelic variants of ABC drug transporter Cdr1p in clinical isolates of Candida albicans. Biochem Biophys Res Commun. 2007;352:491–497. doi: 10.1016/j.bbrc.2006.11.035. PubMed DOI

Feng W, Yang J, Ji Y, Xi Z, Yang L, et al. Mrr2 mutations and upregulation are associated with increased fluconazole resistance in Candida albicans isolates from patients with vulvovaginal candidiasis. Lett Appl Microbiol. 2020;70:95–101. doi: 10.1111/lam.13248. PubMed DOI

Phenotypic and genotypic characterization of Candida parapsilosis complex isolates from a Lebanese hospital